Expanesthetics
Expanesthetics, a California-based company, innovates superior anesthetics and pain-relievers using advanced screening technology.
Founded
2012Expanesthetics, a California-based company, innovates superior anesthetics and pain-relievers using advanced screening technology.
Founded in 2012 and headquartered in Davis, California, Expanesthetics is dedicated to developing superior general anesthetics and pain-relievers. The company leverages its licensed screening technology to identify molecules that offer benefits over existing anesthetics, aiming to reduce unwanted side effects. Expanesthetics focuses on creating innovative inhaled anesthetics that not only enhance clinical outcomes but are also environmentally sustainable.
Expanesthetics has positioned itself as a global leader in the development of new inhaled general anesthetics, with its lead drug candidate being the first to reach the development stage since the early 1990s. Notable affiliated individuals and investors include experts in anesthesiology and pharmaceutical development. The company’s key achievements include advancing the first new inhaled agent in decades and pioneering climate-friendly anesthetic solutions. Through these innovations, Expanesthetics significantly impacts both medical practice and environmental sustainability.
Companies similar to Expanesthetics include Epalex, EicOsis, St. Renatus and Anesthesia Labs.
Expanesthetics was founded in 2012.
Expanesthetics' headquarters is located in Davis, CA, US.
Expanesthetics' most recent funding round was for $659.2k (USD) in September 2023.
As of Sep 8, 2023, Expanesthetics has disclosed funding of $9.2M (USD). Undisclosed round amounts are excluded.
Expanesthetics has 11 employees as of Feb 5, 2024.
Anesthesia Labs
anesthesialabs.com
